Toxic Epidermal Necrolysis-Stevens Johnson Overlap Syndrome: A Case Report
PDF
Cite
Share
Request
Case report
VOLUME: 2 ISSUE: 1
P: 32 - 35
2012

Toxic Epidermal Necrolysis-Stevens Johnson Overlap Syndrome: A Case Report

J Dr Behcet Uz Child Hosp 2012;2(1):32-35
1. Dr. Behçet Uz Child Disease And Surgery Training And Research Hospital, Izmir
No information available.
No information available
Received Date: 2012-02-27T10:38:38
Accepted Date: 2012-04-27T14:39:51
PDF
Cite
Share
Request

Abstract

Toxic epidermal necrolysis is seen rarely. It generally develops secondary to drugs and sometimes infection. It is characterized by peeling of the skin. Morbidity and mortality is very high. There is no definitive consensus about the treatment of toxic epidermal necrolysis. In this article, upper respiratory tract infection developed in male patients of 18 months beginning from 15. days of amoxycilline -clavulanic acid, terbutaline, and ibuprofen treatment with manifestations of skin rashes, and subsequent toxic epidermal necrolysis-Steven Johnson overlap syndrome. the first day follow-up and the three-day (400 mg/kg/day), Intravenous immunoglobulin (IVIG) therapy starting from the first day of follow-up, and maintained for 3 days at a dose of 400 mg/kg/day resulted in a dramatic improvement. With this case report we pointed to a life-threatening side effect of these drugs, and wanted to indicate that IVIG therapy is among effective, and safe therapeutic alternatives.

Keywords:
Toxic epidermal necrolysis, adverse event, intravenous immunoglobulin